GI
BLTE

GAMMA Investing’s Belite Bio BLTE Stock Holding History

GAMMA Investing’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$260K Sell
1,686
-21
-1% -$3.22K 0.01% 1075
2026
Q1 		$272K Sell
1,707
-72
-4% -$12.1K 0.01% 909
2025
Q4 		$285K Buy
1,779
+21
+1% +$2.49K 0.01% 799
2025
Q3 		$130K Buy
1,758
+176
+11% +$11.6K 0.01% 1285
2025
Q2 		$91.3K Sell
1,582
-267
-14% -$16.3K 0.01% 1519
2025
Q1 		$122K Buy
1,849
+559
+43% +$33.7K 0.01% 1089
2024
Q4 		$81.4K Buy
1,290
+419
+48% +$27.6K 0.01% 1267
2024
Q3 		$40.8K Buy
871
+443
+104% +$21.5K ﹤0.01% 1639
2024
Q2 		$19.6K Buy
428
+194
+83% +$8.4K ﹤0.01% 1878
2024
Q1 		$8.98K Buy
234
+35
+18% +$1.57K ﹤0.01% 2123
2023
Q4 		$8.64K Buy
+199
New +$7.65K ﹤0.01% 1985

Other funds holding BLTE

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
HNWAG
High Net Worth Advisory Group Naples, Florida $471M AUM 22.07% 1-Year Est. Return
DACS
Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
EFMH
E Fund Management (HK) Central, Hong Kong $302M AUM 64.42% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
WPA
West Paces Advisors Atlanta, Georgia $596M AUM 22.29% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

GAMMA Investing's BLTE Position: Q2 2026 in Review

GAMMA Investing reduced its Belite Bio (BLTE) stake by 1.2% in Q2 2026, selling an estimated $3.22K and leaving 1,686 shares worth $260K. The position accounts for 0.01% of the portfolio, ranked #1075.

GAMMA Investing first reported a position in BLTE in Q4 2023 and has held it in 11 quarters since. The position peaked at $285K in Q4 2025. 12 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • GAMMA Investing held 1,686 shares of Belite Bio worth $260K as of Q2 2026.
  • GAMMA Investing sold 21 Belite Bio shares in Q2 2026, an estimated $3.22K.
  • Belite Bio made up 0.01% of GAMMA Investing's portfolio in Q2 2026, its #1075 holding.
  • GAMMA Investing first reported a position in Belite Bio in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Belite Bio position peaked at $285K in Q4 2025.
  • 12 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.